MotivationHey Guys/Gals:
Just to speak briefly to the idea that DM is not incentivized to advance this company. I may be wrong on exact numbers, but I believe that with shares, options, RSU's combined Don has around 7 million shares under his belt.
If they can grow this company so that his holdings gain a value of $30-40/unit, you can do the math. What if they managed not to sell this company, and apabetalone went to market, eventually under multiple indications. Can you imagine a scenario where the share price could go to $100? If so, do the math, is Don incentivized?
If Don was 45 years old, he might be thinking about keeping BP away for the triple digit share price. This type of thing does occur in the biotech world. It just requires success and time. We are told time is money, but more importantly as you get older in this world, time is time, kind of like land 'they aren't making more of it'.
I would merely guess that Don would love to sell this company, enjoy the rest of his time in this world, with more than enough money, and generate future oyalties for those he loves.
And so I am guessing that negotiations are ongoing, but somewhat contingent on the possiblity of a Covid home-run. After clarity on that topic emerges, as it relates to apabetalone, then I suspect its decision time for everyone involved.
Hang in there people if you agree.
J4P